Overview
Dr. Ardalan's clinical interests are in juvenile myositis, lupus, and scleroderma and he is co-director of the Duke Children's Myositis Center. He also co-leads the Duke Pediatric Lupus Clinic. Dr. Ardalan's research interests encompass health-related quality of life, patient-reported outcomes, mental health, psychological stress, adverse childhood experiences, cardiovascular health and outcomes research, psychometrics, and qualitative/mixed methods research. His most recent work, funded by the Rheumatology Research Foundation Investigator Award, focuses on the relationships between psychological stress, inflammation, and cardiovascular health in juvenile lupus and dermatomyositis.
Current Appointments & Affiliations
Assistant Professor of Pediatrics
·
2021 - Present
Pediatrics, Rheumatology,
Pediatrics
Recent Publications
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis.
Journal Article Semin Arthritis Rheum · April 2025 OBJECTIVES: Assess reliability and validity of Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric self-report and parent-proxy report fixed short forms in juvenile myositis (JM). METHODS: Children with JM (8-17yo) and parents of 5- ... Full text Link to item CiteApproach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers.
Journal Article Rheumatology (Oxford) · February 10, 2025 OBJECTIVES: Janus kinase inhibition (JAKi) has been proposed as a treatment for idiopathic inflammatory myopathies to target increased interferon signalling. Predominantly retrospective reports have demonstrated effectiveness of JAKi in refractory juvenile ... Full text Link to item CiteRinging in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
Journal Article J Rheumatol · December 1, 2024 Full text Link to item CiteRecent Grants
Using Bioengineered Human Muscle to Develop Treatments for Juvenile Dermatomyositis
ResearchCollaborator · Awarded by Hartwell Foundation · 2025 - 2028CZI JDM Study Stakeholder Engagement
ResearchPrincipal Investigator · Awarded by Cure JM Foundation · 2024 - 2026A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 t
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca AB · 2025 - 2026View All Grants
Education, Training & Certifications
University of Virginia, School of Medicine ·
2009
M.D.